BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 28987239)

  • 1. Dipeptidyl peptidase 4 inhibitor attenuates obesity-induced myocardial fibrosis by inhibiting transforming growth factor-βl and Smad2/3 pathways in high-fat diet-induced obesity rat model.
    Hong SK; Choo EH; Ihm SH; Chang K; Seung KB
    Metabolism; 2017 Nov; 76():42-55. PubMed ID: 28987239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icariside II attenuates myocardial fibrosis by inhibiting nuclear factor-κB and the TGF-β1/Smad2 signalling pathway in spontaneously hypertensive rats.
    Fu S; Li YL; Wu YT; Yue Y; Qian ZQ; Yang DL
    Biomed Pharmacother; 2018 Apr; 100():64-71. PubMed ID: 29421583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
    Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
    Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shensong Yangxin Capsule prevents diabetic myocardial fibrosis by inhibiting TGF-β1/Smad signaling.
    Shen N; Li X; Zhou T; Bilal MU; Du N; Hu Y; Qin W; Xie Y; Wang H; Wu J; Ju J; Fang Z; Wang L; Zhang Y
    J Ethnopharmacol; 2014 Nov; 157():161-70. PubMed ID: 25267579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of LOX by TGF-β1/Smad/AP-1 signaling aggravates rat myocardial fibrosis and heart failure.
    Lu M; Qin Q; Yao J; Sun L; Qin X
    IUBMB Life; 2019 Nov; 71(11):1729-1739. PubMed ID: 31317653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of TGF-β1/Smad signaling pathway by sesamin contributes to the attenuation of myocardial fibrosis in spontaneously hypertensive rats.
    Zhao M; Zheng S; Yang J; Wu Y; Ren Y; Kong X; Li W; Xuan J
    PLoS One; 2015; 10(3):e0121312. PubMed ID: 25793583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats.
    Wang F; Zhang ZF; He YR; Wu HY; Wei SS
    J Obstet Gynaecol Res; 2019 Mar; 45(3):600-608. PubMed ID: 30515927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Transient Receptor Potential Canonical Type 3 Channel via AT1R/TGF-
    He R; Zhang J; Luo D; Yu Y; Chen T; Yang Y; Yu F; Li M
    Oxid Med Cell Longev; 2019; 2019():4025496. PubMed ID: 31871548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Qingda granule attenuates cardiac fibrosis via suppression of the TGF-β1/Smad2/3 signaling pathway in vitro and in vivo.
    Chen X; Long L; Cheng Y; Chu J; Shen Z; Liu L; Li J; Xie Q; Liu H; Wu M; Chen Y; Peng J; Shen A
    Biomed Pharmacother; 2021 May; 137():111318. PubMed ID: 33556875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calhex
    Yuan H; Xu J; Xu X; Gao T; Wang Y; Fan Y; Hu J; Shao Y; Zhao B; Li H; Sun J; Xu C
    Biol Pharm Bull; 2019 Aug; 42(8):1337-1344. PubMed ID: 31167987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
    Lian R; Chen Y; Xu Z; Zhang X
    Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.
    Sun L; Jin H; Sun L; Chen S; Huang Y; Liu J; Li Z; Zhao M; Sun Y; Tang C; Zhao B; Du J
    Mol Med; 2015 Jan; 20(1):503-15. PubMed ID: 25222913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of nuclear factor erythroid 2-related factor 2 signaling and activation of fibrogenic pathways in hearts of high fat diet-fed rats.
    Elrashidy RA
    Mol Biol Rep; 2020 Apr; 47(4):2821-2834. PubMed ID: 32239469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Velvet antler peptide prevents pressure overload-induced cardiac fibrosis via transforming growth factor (TGF)-β1 pathway inhibition.
    Zhao L; Mi Y; Guan H; Xu Y; Mei Y
    Eur J Pharmacol; 2016 Jul; 783():33-46. PubMed ID: 27108788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise Training Alleviates Cardiac Fibrosis through Increasing Fibroblast Growth Factor 21 and Regulating TGF-β1-Smad2/3-MMP2/9 Signaling in Mice with Myocardial Infarction.
    Ma Y; Kuang Y; Bo W; Liang Q; Zhu W; Cai M; Tian Z
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects and mechanism of Compound Qidan Formula on rats with HFpEF induced by hypertension and diabetes mellitus based on Ang Ⅱ/TGF-β1/Smads signaling pathway.
    Yuan P; Liu J; Xiong S; Yang L; Guan J; Dong G; Shi D
    J Ethnopharmacol; 2023 Sep; 313():116558. PubMed ID: 37116729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qiliqiangxin Attenuates Cardiac Remodeling via Inhibition of TGF-β1/Smad3 and NF-κB Signaling Pathways in a Rat Model of Myocardial Infarction.
    Han A; Lu Y; Zheng Q; Zhang J; Zhao Y; Zhao M; Cui X
    Cell Physiol Biochem; 2018; 45(5):1797-1806. PubMed ID: 29510381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of alprostadil on myocardial fibrosis in rats with diabetes mellitus via TGF-β1/Smad signaling pathway.
    Tu JH; Xu Y; Dai Y; Dang L
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9633-9641. PubMed ID: 31773714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin, attenuates cardiac dysfunction after myocardial infarction independently of DPP-4.
    Yamaguchi T; Watanabe A; Tanaka M; Shiota M; Osada-Oka M; Sano S; Yoshiyama M; Miura K; Kitajima S; Matsunaga S; Tomita S; Iwao H; Izumi Y
    J Pharmacol Sci; 2019 Feb; 139(2):112-119. PubMed ID: 30638989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.